HMR 3339, a novel selective estrogen receptor modulator, reduces concentrations of procarboxypeptidase U, an inhibitor of fibrinolysis. A randomized, placebo‐controlled study in postmenopausal women
2005
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
13
References
8
Citations
NaN
KQI